Piramal Pharma Limited announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported a total income of ₹1,483.31 crore for the quarter and a profit after tax of ₹170.74 crore. For the half-year, total income stood at ₹2,722.89 crore with a profit after tax of ₹284.22 crore.
Piramal Pharma Reports Q2 FY27 Standalone Financials
Piramal Pharma Limited has released its unaudited standalone financial results for the second quarter and the first half of the fiscal year ending September 30, 2026. The Board of Directors approved these results during a meeting held on October 27, 2026.
Key Financial Highlights
Quarter Ended September 30, 2026:
- Total Income: ₹1,483.31 crore
- Profit Before Tax: ₹224.60 crore
- Profit After Tax: ₹170.74 crore
Half-Year Ended September 30, 2026:
- Total Income: ₹2,722.89 crore
- Profit Before Tax: ₹374.08 crore
- Profit After Tax: ₹284.22 crore
The company also noted that the meeting of the Board of Directors commenced at 5:30 pm and concluded at 8:30 pm on October 27, 2026.
Source: BSE
